Georges Siotis gratefully acknowledges the financial support from the Ministerio Economía y Competitividad (Spain) grants Beca I3 2006/04050/011, ECO2015-65204-P, MDM 2014-0431, and Comunidad de Madrid grant MadEco-CM (S2015/HUM-3444). Micael Castanheira is “Directeur de recherche” FRS-FNRS and gratefully acknowledges their financial support. There were 28 765 potential medication-CA combinations (523 medications× 55 CAs) and 116 ATC3 groups, with an average of nine (range 1-20) medications and 487 (range 53-1086) medication-CA combinations per group. V IDD Power Supply current VDD5V 180 - 1260 MA R 620 625 G 522.5 525 PEAK WAVELENGTH (PER DOT) B 467.5 470 NM R 360 400 G 550 600 LUMINOUS INTENSITY (PER DOT) B 140 150 MCD FOSC Oscillator Frequency 5. The total number of recorded exposures to these medications was 22 624. We would like to thank two anonymous referees, the Editor, Laurent Bouton, Guilhem Cassan, Christopher Cotton, Raffaele Fiocco, Michel Goldman, Margaret Kyle, Patrick Legros, Alessandro Lizzeri, Laurent Mathevet, Jacopo Perego, Régis Renault, Patrick Rey, Pablo Querubin, Tobias Salz, Fiona Scott Morton, Denni Tommasi, and Philippe Weil for their helpful comments, as well as seminar participants at Oxford University, ECARES, i3h, the Paris School of Economics, Queen's University, Universidad Carlos III, Université de Cergy-Pontoise, Université de Lausanne, EARIE2016, and CRETE2016. in the data was 523, of which 39 (7.5) were coded only to ATC4. ![]() ![]() ![]() The genesis of this paper owes a lot to her insights and enthusiasm. This paper is dedicated to the memory of Maria-Ángeles de Frutos, who passed away just after completing a closely related paper.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |